Thermo Fisher Scientific Reports Third-Quarter Revenue of $12.14 Billion
Third-quarter 2026 revenue rose 9.1% year over year to $12.14 billion. Net income increased 6.5% to $1.72 billion, diluted EPS rose 8.7% to $4.64, and organic revenue growth was 6%.
Thermo Fisher Scientific reported third-quarter 2026 revenue of $12.14 billion, up 9.1% from the prior-year quarter, while net income rose 6.5% to $1.72 billion and diluted EPS increased 8.7% to $4.64. Organic revenue growth was 6%, supported by strength in Laboratory Products and Biopharma Service…